Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Not applicableUnknownNCT04558814
What this trial is testing

Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06581198
What this trial is testing

Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals 179
Post-approval studies (Phase 4)Study completedNCT00911521
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study

Who this might be right for
Systemic Lupus Erythematosus
Tuen Mun Hospital 100
Not applicableLooking for participantsNCT05714930
What this trial is testing

LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Heinrich-Heine University, Duesseldorf 606
Post-approval studies (Phase 4)Study completedNCT02953821
What this trial is testing

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus Erythematosus, Systemic
Mallinckrodt 172
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Early research (Phase 1)Ended earlyNCT06041568
What this trial is testing

Imvotamab in Severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Erythematosus
IGM Biosciences, Inc. 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT00775476
What this trial is testing

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

Who this might be right for
Systemic Lupus Erythematosus
State University of New York - Upstate Medical University 290
Not applicableWithdrawnNCT02270710
What this trial is testing

Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus
Weill Medical College of Cornell University
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895696
What this trial is testing

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Beeline Medicines Corporation 248
Early research (Phase 1)Looking for participantsNCT07483346
What this trial is testing

IASO-782 in Systemic Lupus Erythematosus

Who this might be right for
SLE - Systemic Lupus Erythematosus
Shanghai IASO Biotechnology Co., Ltd 20
Not applicableStudy completedNCT07267091
What this trial is testing

The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study

Who this might be right for
LupusLupus ArthritisLupus Arthritis, Systemic Lupus Erythematosus+1 more
PeriPharm 88
Not applicableLooking for participantsNCT04604990
What this trial is testing

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

Who this might be right for
SLE (Systemic Lupus)
King Saud University 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03747159
What this trial is testing

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Who this might be right for
Lupus Erythematosus, Systemic
Leiden University Medical Center 70
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Early research (Phase 1)Enrolling By InvitationNCT06518668
What this trial is testing

NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Hospital for Special Surgery, New York 6
Testing effectiveness (Phase 2)Study completedNCT01085097
What this trial is testing

Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Teva Branded Pharmaceutical Products R&D, Inc. 46
Early research (Phase 1)UnknownNCT03030976
What this trial is testing

CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Shanghai GeneChem Co., Ltd. 5
Next Page